Renalytix Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	24.68	41.33	65.13	13.29	8.2
Short-Term Investments	0	0.08	0.08	0.98	0.99
Cash & Cash Equivalents	24.68	41.41	65.2	14.28	9.2
Cash Growth	-40.39%	-36.49%	356.76%	55.25%	-
Receivables	0.78	0.9	0.6	0.02	0
Other Current Assets	1.42	2.45	0.99	0.55	0.23
Total Current Assets	26.88	44.75	66.79	14.84	9.42
Property, Plant & Equipment	1.19	1.37	2.49	1.66	0.28
Long-Term Investments	1.46	2.75	9.3	2.02	0
Other Long-Term Assets	1.1	1.19	0	2.36	0
Total Long-Term Assets	3.75	5.31	11.79	6.04	0.28
Total Assets	30.63	50.07	78.58	20.88	9.7
Accounts Payable	2.94	2.46	1.76	2.22	0.32
Deferred Revenue	0	0.05	0.12	0	0
Current Debt	4.59	4.66	0	0.12	0
Other Current Liabilities	8.61	4.61	5.18	0.95	0.83
Total Current Liabilities	16.14	11.78	7.06	3.29	1.15
Long-Term Debt	7.53	7.68	0	0.14	0
Other Long-Term Liabilities	0	0	0.05	1.54	0
Total Long-Term Liabilities	7.53	7.68	0.05	1.68	0
Total Liabilities	23.66	19.46	7.12	4.97	1.15
Total Debt	12.12	12.34	0	0.26	0
Debt Growth	-1.81%	-	-	-	-
Retained Earnings	-178.33	-132.72	-87.44	-52.72	-42.87
Comprehensive Income	-1.45	-0.92	8.28	-1.2	-0.82
Shareholders' Equity	6.97	30.61	71.46	15.91	8.55
Net Cash / Debt	12.56	29.07	65.2	14.02	9.2
Net Cash / Debt Growth	-56.78%	-55.42%	365.07%	52.47%	-
Net Cash Per Share	0.15	0.39	0.91	0.24	0.22
Working Capital	10.75	32.98	59.73	11.55	8.27
Book Value Per Share	0.17	0.84	2.00	0.54	0.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).